Please assess the completion status of the following clinical trial:

Trial Title: Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* WOMEN OVER 40 YEARS, UTERINE VOLUME HIGHER THAN 300 ML, MINIMAL ANATOMIC CONDITIONS FOR VAGINAL SURGERY~Exclusion Criteria:~* ACTIVE GYNECOLOGIC MALIGNANCY

- Gender: FEMALE
- Minimum Age: 40 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- AROMATASE INHIBITOR (Type: EXPERIMENTAL): this would be compared before and after VAGINAL HYSTERECTOMY
- GNRH ANALOG (Type: ACTIVE_COMPARATOR): this would be compared before and after VAGINAL HYSTERECTOMY

Based on this trial design, predict the completion outcome and termination type (if applicable).